McKesson (MCK) stock price, revenue, and financials

McKesson market cap is $26.5 b, and annual revenue was $231.05 b in FY 2020

$26.5 B

MCK Mkt cap, 22-May-2020

$231.1 B

McKesson Revenue FY, 2020
McKesson Gross profit (FY, 2020)12 B
McKesson Gross profit margin (FY, 2020), %5.2%
McKesson Net income (FY, 2020)1.1 B
McKesson EBIT (FY, 2020)2.5 B
McKesson Cash, 31-Mar-20204 B
McKesson EV31.8 B

McKesson Revenue

McKesson revenue was $231.05 b in FY, 2020

Embed Graph

McKesson Revenue Breakdown

Embed Graph

McKesson revenue breakdown by business segment: 5.5% from Other , 78.3% from U.S. Pharmaceutical and Specialty Solutions, 12.7% from European Pharmaceutical Solutions and 3.6% from Other

McKesson revenue breakdown by geographic segment: 17.7% from Foreign and 82.3% from United States

McKesson Income Statement

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

198.5b208.4b214.3b231.1b

Revenue growth, %

5%3%

Cost of goods sold

187.3b197.2b202.6b219.0b

Gross profit

11.3b11.2b11.8b12.0b

Gross profit Margin, %

6%5%5%5%

R&D expense

341.0m125.0m71.0m

General and administrative expense

7.5b8.1b8.4b

Operating expense total

(4.2b)10.4b10.9b9.5b

EBIT

7.1b762.0m886.0m2.5b

EBIT margin, %

4%0%0%1%

Interest expense

308.0m283.0m264.0m

Pre tax profit

6.9b239.0m610.0m1.1b

Income tax expense

1.6b(53.0m)356.0m18.0m

Net Income

5.2b297.0m255.0m1.1b

McKesson Balance Sheet

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

2.8b2.7b3.0b4.0b

Accounts Receivable

18.2b17.7m18.2b20.0b

Prepaid Expenses

617.0m

Inventories

15.3b16.3b16.7b16.7b

Current Assets

36.9b37.1b38.5b42.2b

PP&E

2.3b2.5b2.5b2.4b

Goodwill

10.6b10.9b9.4b9.4b

Total Assets

61.0b60.4b59.7b61.2b

Accounts Payable

31.0b32.2b33.9b37.2b

Short-term debt

1.2b1.1b330.0m1.4b

Current Liabilities

35.6b36.7b37.6b42.6b

Long-term debt

7.3b6.8b7.3b8.0b

Total Debt

8.5b7.9b7.6b9.4b

Total Liabilities

49.7b50.3b51.4b

Common Stock

3.0m3.0m3.0m2.0m

Preferred Stock

Additional Paid-in Capital

6.0b6.2b6.4b6.7b

Retained Earnings

13.2b13.0b12.4b13.0b

Total Equity

11.3b10.1b8.3b5.3b

Debt to Equity Ratio

0.8 x0.8 x0.9 x

Debt to Assets Ratio

0.1 x0.1 x0.1 x

Financial Leverage

5.4 x6 x7.2 x11.5 x

Quarterly

USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

2.3b2.6b2.6b2.2b2.1b1.8b1.9b1.4b2.1b

Accounts Receivable

19.1b19.6b20.0b19.1b19.2b18.9b19.3b19.0b18.8b

Prepaid Expenses

590.0m657.0m618.0m

Inventories

15.5b16.9b17.1b16.4b16.7b17.0b16.6b16.4b17.0b

Current Assets

37.7b39.8b40.2b38.2b38.5b38.3b38.4b37.4b39.4b

PP&E

2.3b2.3b2.4b2.5b2.5b2.5b2.5b2.5b2.4b

Goodwill

11.8b11.7b11.8b10.6b10.6b10.5b9.4b9.4b9.5b

Total Assets

61.8b63.8b64.2b61.3b61.4b61.0b61.7b59.0b60.9b

Accounts Payable

32.0b33.6b33.0b32.1b33.2b32.1b34.0b32.6b32.7b

Short-term debt

528.0m831.0m1.3b3.2b2.5b2.2b310.0m851.0m3.1b

Current Liabilities

35.8b37.8b37.7b38.3b38.9b37.4b38.0b37.1b40.1b

Long-term debt

7.4b7.5b7.5b6.6b6.6b7.6b9.2b9.1b8.5b

Total Debt

8.0b8.3b8.8b9.8b9.1b9.8b9.5b10.0b11.6b

Total Liabilities

50.3b52.5b52.2b51.6b51.9b51.6b

Common Stock

3.0m3.0m3.0m3.0m3.0m3.0m3.0m3.0m3.0m

Preferred Stock

Additional Paid-in Capital

6.1b6.1b6.3b6.4b6.4b6.3b6.5b6.6b6.6b

Retained Earnings

13.4b13.4b14.2b12.9b13.4b13.3b12.8b12.0b12.1b

Total Equity

11.5b11.4b12.0b9.6b9.5b9.4b8.1b6.7b6.4b

Debt to Equity Ratio

0.7 x0.7 x0.7 x1 x1 x1 x

Debt to Assets Ratio

0.1 x0.1 x0.1 x0.2 x0.1 x0.2 x

Financial Leverage

5.4 x5.6 x5.4 x6.4 x6.4 x6.5 x7.6 x8.8 x9.5 x

McKesson Cash Flow

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

5.2b297.0m255.0m1.1b

Depreciation and Amortization

910.0m951.0m949.0m922.0m

Accounts Receivable

(762.0m)1.2b(967.0m)(2.5b)

Inventories

320.0m(458.0m)(368.0m)(376.0m)

Accounts Payable

2.1b271.0m2.0b4.0b

Cash From Operating Activities

4.7b4.3b4.0b4.4b

Purchases of PP&E

(404.0m)(405.0m)(426.0m)(362.0m)

Cash From Investing Activities

(3.8b)(1.5b)(1.4b)(579.0m)

Short-term Borrowings

(8.1b)(20.7b)(37.3b)(21.4b)

Long-term Borrowings

(1.6b)(2.3b)(1.1b)(298.0m)

Dividends Paid

(253.0m)(262.0m)(292.0m)(294.0m)

Cash From Financing Activities

(2.1b)(3.1b)(2.2b)(2.7b)

Net Change in Cash

(1.3b)(111.0m)309.0m1.0b

Interest Paid

315.0m298.0m383.0m235.0m

Income Taxes Paid

587.0m144.0m262.0m368.0m

Quarterly

USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

365.0m421.0m1.4b(80.0m)473.0m999.0m477.0m(200.0m)42.0m

Depreciation and Amortization

227.0m463.0m697.0m235.0m475.0m714.0m229.0m463.0m691.0m

Accounts Receivable

(363.0m)(812.0m)(1.0b)(1.4b)(1.7b)(1.5b)(1.1b)(866.0m)(1.0b)

Inventories

(59.0m)(1.2b)(1.4b)(114.0m)(398.0m)(756.0m)145.0m331.0m(689.0m)

Accounts Payable

463.0m1.8b1.2b32.0m1.2b175.0m127.0m(1.2b)(929.0m)

Cash From Operating Activities

741.0m1.3b1.3b(1.1b)318.0m141.0m(51.0m)(159.0m)(280.0m)

Purchases of PP&E

(75.0m)(164.0m)(269.0m)(101.0m)(178.0m)(309.0m)(87.0m)(126.0m)(242.0m)

Cash From Investing Activities

(129.0m)(396.0m)(483.0m)(875.0m)(983.0m)(1.2b)(129.0m)(285.0m)(409.0m)

Short-term Borrowings

(2.5b)(8.3b)(12.1b)(7.0b)(18.3b)(29.3b)(2.6b)(8.1b)(13.7b)

Long-term Borrowings

(541.0m)(545.0m)(545.0m)(2.0m)(5.0m)(14.0m)

Dividends Paid

(62.0m)(121.0m)(192.0m)(71.0m)(139.0m)(216.0m)(75.0m)(148.0m)(222.0m)

Cash From Financing Activities

(1.1b)(1.3b)(1.1b)1.5b198.0m317.0m(872.0m)(1.2b)(254.0m)

Net Change in Cash

(444.0m)(1.3b)(1.1b)(473.0m)(554.0m)(823.0m)(1.0b)(1.6b)(916.0m)

McKesson Ratios

USDY, 2020

EV/EBIT

12.8 x

EV/CFO

7.3 x

Financial Leverage

11.5 x

McKesson Operating Metrics

FY, 2017FY, 2018FY, 2019

Participant Pharmacies

5.50 k7 k6.90 k

Pharmacies Owned

2.40 k2 k2 k

Pharmacies Served

50 k

McKesson Employee Rating

3.33274 votes
Culture & Values
3.3
Work/Life Balance
3.3
Senior Management
3.0
Salary & Benefits
3.5
Career Opportunities
3.1
Source